Most patients with advanced systolic dysfunction who are assessed for a left ventricular
assist device (LVAD) also have some degree of right ventricular (RV) dysfunction. Hence …

Mechanical circulatory assist devices are now commonly used in the treatment of severe
heart failure as bridges to cardiac transplant, as destination therapy for patients who are not …

Objectives: This study tested whether combined invasive hemodynamic and
echocardiographic ramp tests can help optimize patient management. Background …

Despite significant efforts to predict and prevent right heart failure, it remains a leading
cause of morbidity and mortality after implantation of left ventricular assist systems (LVAS). In …

After implantation of a continuous-flow left ventricular assist device (CF-LVAD), exercise
capacity in heart failure patients remains reduced with peak oxygen uptake (peak VO 2) …

Background Right ventricular (RV) failure is a source of morbidity and mortality after left
ventricular assist device (LVAD) implantation. In this study we sought to define …

Background Performing concomitant tricuspid valve procedures (TVPs) in left ventricular
assist device (LVAD) patients with significant pre-operative tricuspid regurgitation (TR) is …

OBJECTIVES Data on the impact and course of uncorrected tricuspid regurgitation (TR)
during left ventricular assist device (LVAD) implantation are scarce and inconsistent. This …

Background The HeartMate 3 (HM3) is a Conformiteé Européenne (CE) mark–approved left
ventricular assist device (LVAD) with a fully magnetically levitated rotor with features …

Background: Acute right heart failure (RHF) after left ventricular assist device implantation
remains a major source of morbidity and mortality, yet the definition of RHF and the …